TickerKhojComparison · NSE · data 2026-11-03
Jubilant Ingrevia Ltd. vs Privi Speciality Chemicals Limited
In plain words
Size: Privi Speciality Chemicals Limited is about 1.4 times the market value of Jubilant Ingrevia Ltd..
Valuation (P/E): Privi Speciality Chemicals Limited 34.3 vs Jubilant Ingrevia Ltd. 25.5.
Return on equity: Privi Speciality Chemicals Limited 26% vs Jubilant Ingrevia Ltd. 9.2%.
Profit growth over 3 years: Privi Speciality Chemicals Limited 145.2% a year vs Jubilant Ingrevia Ltd. -3.3% a year.
Debt to equity: Privi Speciality Chemicals Limited 0.7 vs Jubilant Ingrevia Ltd. 0.25.
Differences in the numbers, not a recommendation of either stock.
Open visual comparison → Explore metric gaps, choose a reference company and compare up to four stocks.
Side by side
19 metrics shown
| JUBLINGREA | PRIVISCL | |
|---|---|---|
| Price | ₹563.7 | ₹3,271.4 |
| Market cap | ₹9,123 cr | ₹12,825 cr |
| P/E | 25.5 | 34.3 |
| P/B | 2.7 | 8.1 |
| ROE | 9.2% | 26.0% |
| ROCE | 10.4% | 26.8% |
| Debt / equity | 0.25 | 0.7 |
| Operating margin | 10.3% | 19.5% |
| Dividend yield | 0.87% | 0.30% |
| Sales growth, 3 years (yearly) | -2.9% | 16.7% |
| Profit growth, 3 years (yearly) | -3.3% | 145.2% |
| 1-year return | -18.4% | 12.7% |
| Revenue, last 12 months | ₹4,924 cr | ₹2,753 cr |
| Net profit, last 12 months | ₹351 cr | ₹373 cr |
| Latest quarter | Sept 2026 | Sept 2026 |
| Quarter net profit | ₹111 cr | ₹117 cr |
| Quarter profit vs a year earlier | +60.4% | +29.7% |
| Promoter holding | 45.22% | 60.60% |
| Health check | Average (4.7/10) | Strong (6.9/10) |
Common questions
Which has a higher P/E, Jubilant Ingrevia Ltd. or Privi Speciality Chemicals Limited?
Privi Speciality Chemicals Limited trades at the higher P/E (34.3 against 25.5). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Privi Speciality Chemicals Limited (26.0% against 9.2%).
Which carries more debt?
Privi Speciality Chemicals Limited has the higher debt-to-equity ratio (0.7 against 0.25).